Company record
Namita A. Goyal, M.D.
1 FDA warning letter since 2023 and 0 recalls in the last 12 months.
Get an email the day FDA posts anything new about Namita A. Goyal, M.D..
Warning letters
-
BiologicsNamita A. Goyal, M.D.
FDA warned clinical investigator Dr. Namita Goyal over a biologic trial that enrolled ineligible subjects and kept poor records.
High risk